» Authors » Guylene Le Meur

Guylene Le Meur

Explore the profile of Guylene Le Meur including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 631
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Talarico M, de Bellescize J, De Wachter M, Le Guillou X, Le Meur G, Egloff M, et al.
Genet Med . 2024 Dec; 27(4):101347. PMID: 39707840
Purpose: RORA encodes the RAR-related orphan receptor-α, playing a pivotal role in cerebellar maturation and function. Here, we report the largest series of individuals with RORA-related-neurodevelopmental disorder. Methods: Forty individuals...
2.
Lebranchu P, Mazhar D, Wiertlewski S, Le Meur G, Couturier J, Ducloyer J
Mult Scler Relat Disord . 2024 Dec; 93:106213. PMID: 39662165
Purpose: The last updates to diagnostic criteria for multiple sclerosis (MS) included a diagnostic category of 'possible MS'. However, no recent data is available to assess how much this distinction...
3.
Courdier C, Dhaenens C, Grunewald O, Guerrot A, Audo I, Lecleire-Collet A, et al.
Ophthalmic Genet . 2024 Nov; :1-8. PMID: 39610034
Introduction: Classically, Usher syndrome is characterized by the association of sensorineural hearing loss (SNHL), retinitis pigmentosa (RP) and possible vestibular dysfunction. Pathogenic bi-allelic variants in cause atypical autosomal recessive Usher...
4.
Ducloyer J, Poinas A, Duchesne L, Caillet P, Lejus-Bourdeau C, Le Meur G, et al.
BMC Med Educ . 2024 Oct; 24(1):1078. PMID: 39350156
Introduction: Training novice ophthalmology residents on the EyeSi simulator increases cataract surgery safety. However, there is no consensus regarding how much training residents should perform before their first time on...
5.
Mainguy A, Dhaenens C, Poncet A, Billaud F, Giraud L, Zanlonghi X, et al.
Ophthalmic Genet . 2024 Jul; 45(5):470-475. PMID: 38957071
Background: This case report explores the relationship between genetics and phenotypic variability in autosomal dominant vitreoretinochoroidopathy (ADVIRC). The study focuses on a case presenting a novel mutation in the gene...
6.
Ducloyer J, Jossic F, VAN Goethem V, Lebosse D, Cornee C, Le Meur G, et al.
Int J Legal Med . 2024 Apr; 138(5):1867-1872. PMID: 38652283
In living children, the use of a wide field fundus camera such as RetCam is the gold standard practice to document retinal haemorrhages in suspected cases of abusive head trauma...
7.
Mevel M, Pichard V, Bouzelha M, Alvarez-Dorta D, Lalys P, Provost N, et al.
Mol Ther Methods Clin Dev . 2024 Feb; 32(1):101187. PMID: 38327809
Inherited retinal diseases are a leading and untreatable cause of blindness and are therefore candidate diseases for gene therapy. Recombinant vectors derived from adeno-associated virus (rAAV) are currently the most...
8.
Crozet A, Leclere B, Martin F, Goronflot T, Cazet L, Ducloyer J, et al.
Acta Ophthalmol . 2024 Feb; 102(5):e789-e796. PMID: 38308458
Background: The 30-day readmission rate provides a standardised quantitative evaluation of some postoperative complications. It is widely used worldwide in many medical and surgical specialities, and the World Health Organization...
9.
Rousseau N, Lebreton O, Masse H, Maucourant Y, Pipelart V, Clement M, et al.
Ophthalmol Ther . 2023 Jun; 12(5):2781-2792. PMID: 37369907
Introduction: The aim of this study was to assess the efficacy and safety of fluocinolone acetonide implant (FAci) injected 1 month after the last dexamethasone intravitreal implant (DEXi) in chronic...
10.
Ducloyer J, Pichard V, Mevel M, Galy A, Lefevre G, Brument N, et al.
Mol Ther Methods Clin Dev . 2023 Mar; 28:387-393. PMID: 36874242
The subretinal injection protocol for the only approved retinal gene therapy (voretigene neparvovec-rzyl) includes air tamponade at the end of the procedure, but its effects on the subretinal bleb have...